Quantum AI Speedup: Norma achieved up to 73x faster performance in drug development using NVIDIA CUDA-Q.
Hybrid Computing: CUDA-Q’s integration of GPUs and QPUs enhances algorithm efficiency.
Broad Applications: Norma plans to expand quantum AI testing into biotechnology, defense, and finance.
Quantum AI Drug Discovery: Reshaping Healthcare
Quantum AI drug discovery is reshaping healthcare, and Norma, a South Korean quantum computing company, leads the charge. By leveraging NVIDIA’s CUDA-Q platform, Norma achieved a 73x speedup in quantum AI algorithms, slashing the time needed to identify drug candidates. Announced on September 1, 2025, in Seoul, this milestone showcases hybrid computing’s potential. For example, Norma’s work with Kyung Hee University Hospital at Gangdong proves quantum AI’s real-world impact.
Overcoming Computational Bottlenecks
Drug discovery faces challenges due to vast chemical search spaces that slow traditional AI methods. Norma’s team developed quantum algorithms—QLSTM, QGAN, and QCBM—to tackle these issues. Tested on NVIDIA’s GH200 and H200 GPUs, these algorithms delivered 60.14 to 73.32 times faster forward propagation. Additionally, they achieved 33.69 to 41.56 times faster backward propagation, outperforming CPU-based simulators.
“This project is a meaningful example of collaboration between domestic and international quantum technology companies and hospitals, showcasing the practical potential of quantum technologies.”
— Hyunchul Jung, CEO, Norma
The Power of NVIDIA CUDA-Q
NVIDIA’s CUDA-Q platform drives Norma’s success by integrating GPUs and QPUs for efficient hybrid computing. This setup allows algorithm validation in simulated environments, cutting costs and time. For instance, the GH200 outperformed the H200 by 22% in forward propagation. Consequently, CUDA-Q is ideal for precision-driven tasks like drug discovery.
Collaborative Innovation
Norma’s partnership with Kyung Hee University Hospital at Gangdong applies quantum AI to identify novel drug candidates. By collaborating with NVIDIA and academia, Norma ensures scalable innovations. Moreover, the company plans to test quantum AI in biotechnology, defense, and finance. This broadens the technology’s impact across industries.
Shaping Industries
Norma’s 73x speedup shortens drug development timelines, potentially reducing costs and accelerating treatments. These algorithms also provide insights for future quantum hardware. Beyond healthcare, applications in materials science and finance are emerging. As a result, quantum AI drug discovery is poised to reshape multiple sectors.
Looking Ahead
Norma’s milestone signals a bright future for quantum computing applications. Continued collaboration with NVIDIA will drive further innovation. For those interested in quantum AI’s potential, Norma’s work is a beacon of progress. Stay updated on their advancements to witness the next wave of innovation.
